Morgan Stanley initiated coverage on Crinetics Pharmaceuticals with a new price target

1/16/24 6:51:59 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Morgan Stanley initiated coverage of Crinetics Pharmaceuticals with a rating of Overweight and set a new price target of $50.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CRNX

Date	Price Target	Rating	Analyst
3/25/2025	$60.00	Buy	Stifel
2/11/2025		Buy	TD Cowen
2/4/2025		Peer Perform	Wolfe Research
1/22/2025	$55.00	Hold → Buy	Jefferies
3/6/2024	$68.00	Buy	Citigroup
1/16/2024	$50.00	Overweight	Morgan Stanley
12/21/2023	$35.00	Hold	Jefferies
11/20/2023	$35.00	Overweight	JP Morgan